Biocon Patents – Insights & Stats (Updated 2023)

Biocon has a total of 1721 patents globally, out of which 878 have been granted. Of these 1721 patents, more than 38% patents are active. United States of America is where Biocon has filed the maximum number of patents, followed by India and Europe. Parallelly, India seems to be the main focused R&D centre and also is the origin country of Biocon.

Biocon was founded in the year 1978. The Company is a fully integrated healthcare company that delivers innovative biopharmaceutical solutions. From discovery to development and commercialisation, Company has the defining science, cost-effective drug development capabilities and significant manufacturing capacity to move ideas to market.

Do read about some of the most popular patents of Biocon which have been covered by us in this article and also you can find Biocon patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Biocon patent portfolio.

How many patents does the founder and the CEO of Biocon have?

The founder Kiran Mazumdar-Shaw has 12 patents and CEO Siddharth Mittal has 0 patent.

How many patents does Biocon have?

Biocon has a total of 1721 patents globally. These patents belong to 425 unique patent families. Out of 1721 patents, 670 patents are active.

How Many Patents did Biocon File Every Year?

Biocon Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantBiocon Applications FiledBiocon Patents Granted
2023128
20221939
20212149
20203440
20192242
20186764
20176952
20166261
20151949
201410731
20136248
20126341

Explore the top-performing drugs that dominate the Pharmaceutical Industry

Patent NumberCompanyProductBrandRevenuePatent Expiry Date
US9174975Sumitomo PharmaLurasidone HydrochlorideLatuda$1.75BJun-26
US7612199AlfasigmaRifaximinXifaxan$1.64BNov-24
US7902206AlfasigmaRifaximinXifaxan$1.64BNov-24
US8158644AlfasigmaRifaximinXifaxan$1.64BNov-24
US7371727Ironwood PharmaLinaclotideLinzess$1.00BMar-25

How many Biocon patents are Alive/Dead?

Biocon Patent Portfolio

How Many Patents did Biocon File in Different Countries?

Biocon Worldwide Patent Filing

Countries in which Biocon Filed Patents

CountryPatents
United States Of America207
India156
Europe117
Australia113
Japan106
Germany66
Canada65
Austria62
Korea (South)60
China55
Russia50
Brazil45
Mexico44
Spain42
Hong Kong (S.A.R.)36
Israel34
Denmark33
Poland31
New Zealand30
Malaysia26
Portugal22
South Africa20
Singapore17
Taiwan13
Argentina11
Hungary7
Indonesia6
Saudi Arabia6
Ukraine6
Norway5
Czech Republic5
Cyprus5
Chile4
Italy4
United Arab Emirates4
Slovenia4
Slovakia4
Cuba4
Colombia3
Estonia3
Peru3
Viet Nam3
Croatia3
Uruguay2
Eurasia2
Philippines2
Romania1
Malta1
Kazakhstan1
Latvia1

Where are Research Centres of Biocon Patents Located?

R&D Centers of Biocon

10 Best Biocon Patents

US6600201B2 is the most popular patent in the Biocon portfolio. It has received 224 citations so far from companies like Hewlett-Packard Development Company, Qualcomm Mems Technologies and Idc, Llc.

Below is the list of 10 most cited patents of Biocon:

Publication NumberCitation Count
US6600201B2224
WO2006076471A2134
US6858580B2128
WO2013164694A1125
US6703381B1105
WO2011061712A186
US6713454B182
US7030084B280
WO2009113083A179
WO2012147053A171

How many inventions of other companies were rejected due to Biocon patents?

The statistics below share strategic R&D insights. It tells the companies that were trying to protect inventions similar to Biocon invention. They couldn’t because Biocon had protected those before them.

Examiners at the USPTO referred 37 Biocon patents in 131 rejections (35 USC § 102 or 35 USC § 103 types).

The top citing companies in the Biocon patent portfolio are Nektar Therapeutics, Novo Nordisk and Merck Patent.

List of the Companies whose Patents were rejected citing Biocon –

CompanyNumber of Patent Applications that faced Rejection Citing Biocon PatentsNumber of Rejections (102 & 103)
Nektar Therapeutics510
Novo Nordisk513
Merck Patent48
Immunomedics33
Upjohn22
Biomarin Pharmaceutical22
Heat Biologics22
Igisu24
Phyton Holdings11
Neuren Pharmaceuticals12

Count of 102 and 103 Type Rejections based on Biocon Patents

Top Biocon Patents used in Rejecting Most Patent Applications

Patent NumberCount of Rejected Applications
US8815247B212
US20040152769A15
US7875700B24
US7605123B24
US7648962B24
US6664095B13
US7060675B22
US7230120B22
US20080243923A12
US6770625B22
US8133716B22
US6835802B22
US6858580B22
US6541508B21
US20100029933A11

What Percentage of Biocon US Patent Applications were Granted?

Biocon (Excluding its subsidiaries) has filed 208 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 135 have been granted leading to a grant rate of 79.88%.

Below are the key stats of Biocon patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for Biocon?

Law FirmTotal ApplicationsSuccess Rate
Moore & Van Allen9682.76%
Schwegman Lundberg & Woessner2986.21%
Myers Bigel1875.00%
Cooley1477.78%
Katten Muchin Rosenman1390.91%
Olive Law Group580.00%
Caesar Rivise366.67%
Dla Piper30.00%
Harness Dickey Troy30.00%
Ballard Spahr250.00%

What are Biocon key innovation segments?

What Technologies are Covered by Biocon?

The chart below distributes patents filed by Biocon in different countries on the basis of the technology protected in patents. It also represents the markets where Biocon thinks it’s important to protect particular technology inventions.

R&D Focus: How has Biocon search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Biocon?

Table of Content

Insights you may find interesting

Related Articles

Driveu Patents – Insights & Stats (Updated 2024)

Driveu has a total of 12 patents globally, out of which 8 have been granted. Of these 12 patents, more than 91% patents are active. Israel is where Driveu has filed the maximum number of patents, followed by United States of America and Europe (EPO). Parallelly, United States of America

Read More »

Was this article helpful?

Leave a Comment

Fill the form to get the details:

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.